| Literature DB >> 21102587 |
J R B Musselman1, L G Spector.
Abstract
BACKGROUND: There is increasing interest in the possible association between cancer incidence and vitamin D through its role as a regulator of cell growth and differentiation. Epidemiological studies in adults and one paediatric study suggest an inverse association between sunlight exposure and cancer incidence.Entities:
Mesh:
Year: 2010 PMID: 21102587 PMCID: PMC3039792 DOI: 10.1038/sj.bjc.6606015
Source DB: PubMed Journal: Br J Cancer ISSN: 0007-0920 Impact factor: 7.640
Classification of cancer registries by latitude and annual radiation
|
|
| ||
|---|---|---|---|
|
|
|
|
|
| 0–10° | — | Nigeria (1985–1992, 70.5, 383), Colombia (1982–1991, 123.7, 514), Costa Rica (1984–1992, 136.3, 1202), Ecuador (1985–1992, 125.5, 368), Singapore-Chinese (1983–1992, 129.3, 587), Singapore-Malay (1968–1992, 89.4, 251), Papua New Guinea (1979–1988, –, 405) | Uganda (1992–1995, 182.7, 340), Brazil-Belem (1987–1991, 101.9, 212) |
| 11–20° | — | Philippines (1983–1992, 100.8, 2727) | Malawi (1991–1995, 182.7, 340), Mali (1991–1995, –, 547), Namibia (1983–1992, 45.9, 241), Zimbabwe (1990–1994, 111.6, 219), Brazil-Goiania (1987–1997, 122.1, 201), Peru (1990–1991, 104.4, 383), Puerto Rico (1983–1991, 118.5, 951), India-Bangalore (1982–1992, 65.2, 881), India-Bombay (1980–1992, 77.3, 2801), India-Madras (1982–1992, 84.2, 1077), India-Poona (1980–1992, 74.0, 664), Thailand (1983–1993, 73.7, 1086) |
| 21–30° | — | Bangladesh (1982–1992, –, 1650), Hong Kong (1980–1989, 132.1, 1639), Vietnam (1991–1994, 109.7, 295) | South Africa-White (1988–1991, –, 875), South Africa-Black (1988–1991, –, 2524), Cuba (1986–1990, 121.8, 1478), United States-Hawaii (1973–1992, 144.2, 193), India-Delhi (1988–1992, 108.1, 1535), Kuwait-Kuwaiti (1983–1989 and 1992–1993, 108.8, 327), Kuwait-non-Kuwaiti (1983–1989 and 1992–1993, 131.1, 325), United Arab Emirates (1984–1992, –, 332) |
| 31–40° | Japan-Osaka (1981–1989,133.4, 2003), New Zealand-Maori (1980–1992, 151.7, 374), New Zealand-non-Maori (1980–1992, 159.4, 1391) | Algeria (1986–1995, 69.8, 370), Uruguay (1988–1992, 120.2, 468), United States-Delaware Valley-White (1980–1989, 144.5, 2018), United States-Delaware Valley-Black (1980–1989, 108.7, 323), United States-SEER-White (1983–1992, 150.3, 5718), United States-SEER-Black (1983–1992, 117.9, 758), China (1981–1992, 104.9, 783), Japan (1980–1992, 116.3, 4476), South Korea (1992–1994, 108.4, 782), Portugal (1989–1992, 159.3, 680), Spain (1980–1991, 141.3, 1885), Spain-Valencia (1983–1990, 145.6, 509), Pakistan (1984–1993, –, 332) | Egypt (1980–1989, 101.4, 1315), United States-Los Angeles-Hispanic (1984–1992, 160.6, 1134), United States-Los Angeles-non-Hispanic White (1984–1992, 163.5, 899), United States-Los Angeles-Black (1984–1992, 113.7, 247), Israel-Jews (1980–1989, 132.8, 1371), Israel-non-Jews (1980–1989, 111.1, 358), Australia (1982–1991, 142.4, 5112) |
| 41–50° | Canada (1982–1991, 149.2, 7260), Croatia (1987–1990, 169.4, 619), Czech Republic (1980–1989, 125.4, 2894), France (1983–1992, 134.8, 2538), France-Lorraine (1983–1992, 138.7, 668), Hungary (1985–1990, 112.1, 1391), Italy-Piedmont (1982–1989, 145.5, 750), Slovakia (1980–1989, 129.2, 1690), Slovenia (1981, 1990, 118.9, 488), Switzerland (1980–1992, 144.4, 931) | United States-New York-White (1983–1991, 148.7, 3584), United States-New York-Black (1983–1991, 109.4, 719), Bulgaria (1980–1989, 99.6, 1906), France-PACA & Corsica (1984–1992, 135.8, 975), Italy (1980–1991, 143.4, 1638) | — |
| 51–60° | Denmark (1983–1991, 158.7, 1241), Estonia (1980–1989, 125.9, 416), Germany-former German Democratic Republic (1981–1989, 127.8, 3653), Germany-former Federal Republic of Germany (1985–1990, 132.0, 7036), Germany (1991–1995, 132.6, 8434), Netherlands (1989–1992, 135.2, 1457), Poland (1980–1989, 113.1, 651), Sweden (1983–1989, 154.3, 1590), the United Kingdom—England and Wales (1981–1990, 122.1, 11352), the United Kingdom-Scotland (1981–1990, 124.9, 1201) | — | — |
| 60–70° | Finland (1980–1989, 153.5, 1420), Iceland (1960–1989, 110.8, 211), Norway (1980–1989, 151.9, 1201) | — | — |
Dates of registry, age standardized rate, total number of cases.
GINI index and gross domestic product quartile for each registrya
|
|
| |||
|---|---|---|---|---|
|
|
|
|
|
|
| 1 | Bangladesh | Cuba, Bulgaria, Czech Republic, Hungary, Poland, Slovakia, Slovenia | Germany-former German Democratic Republic, Germany-former Federal Republic of Germany, Iceland, United Kingdom-England and Wales, United Kingdom-Scotland | Kuwait, Denmark, Finland, Germany, Netherlands, Norway, Sweden, United Arab Emirates |
| 2 | China, India-Bangalore, India-Bombay, India-Madras, India-Poona, India-Delhi | Spain | Korea, Italy, Italy-Piedmont, New Zealand | Canada, France, France-Lorraine, France-PACA and Corsica, Japan, Australia |
| 3 | Egypt, Vietnam, Pakistan | Algeria, Croatia, Estonia | Israel, Portugal | United States-Greater Delaware Valley, United States-Los Angeles, United States-New York, United States SEER, United States-Hawaii, Japan-Osaka, Switzerland |
| 4 | Malawi, Mali, Nigeria, Uganda, Zimbabwe, Colombia, Ecuador, Peru, Philippines, Thailand, Papua New Guinea | Namibia, South Africa, Brazil, Costa Rica, Uruguay, Singapore-Malay | Puerto Rico, Singapore-Chinese, Hong Kong | — |
Calculated for each registry from data from the follow-up period of that registry.
Lower GINI indicates more equal dispersion of wealth.
Estimated rate ratios for association between latitude and childhood cancer
|
|
|
| |||||||
|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
| 1.05 | 1.02, 1.07 | ** | 1.07 | 1.04, 1.11 | ** | 1.01 | 0.97, 1.05 | 0.58 |
| Lymphoid leukaemia | 1.09 | 1.06, 1.12 | ** | 1.12 | 1.07, 1.17 | ** | 1.00 | 0.95, 1.04 | 0.87 |
| Acute nonlymphocytic leukaemia | 1.02 | 0.99, 1.05 | 0.18 | 1.03 | 0.99, 1.08 | 0.13 | 0.98 | 0.93, 1.03 | 0.45 |
|
| 0.86 | 0.83, 0.89 | ** | 0.91 | 0.86, 0.96 | * | 0.96 | 0.90, 1.02 | 0.19 |
| Hodgkins disease | 0.99 | 0.94, 1.03 | 0.61 | 0.91 | 0.86, 0.98 | * | 0.92 | 0.85, 1.00 | 0.05 |
| Non-Hodgkin lymphoma | 1.02 | 0.99, 1.06 | 0.17 | 0.96 | 0.91, 1.00 | 0.07 | 0.97 | 0.91, 1.03 | 0.29 |
| Brain and spinal neoplasms | 1.24 | 1.21, 1.27 | ** | 1.24 | 1.20, 1.28 | ** | 1.11 | 1.07, 1.15 | ** |
| Sympathetic nervous system tumours | 1.18 | 1.13, 1.23 | ** | 1.13 | 1.06, 1.19 | ** | 0.95 | 0.89, 1.01 | 0.06 |
| Retinoblastoma | 0.80 | 0.76, 0.84 | ** | 0.82 | 0.76, 0.88 | ** | 0.90 | 0.83, 0.98 | 0.02 |
| Renal tumours | 1.08 | 1.05, 1.12 | ** | 1.18 | 1.13, 1.24 | ** | 1.14 | 1.08, 1.21 | ** |
| Hepatic tumours | 0.87 | 0.82, 0.92 | ** | 0.94 | 0.87, 1.02 | 0.14 | 0.96 | 0.87, 1.07 | 0.45 |
| Malignant bone tumours | 1.05 | 1.02, 1.08 | * | 1.05 | 1.02, 1.09 | ** | 1.01 | 0.96, 1.06 | 0.73 |
| Soft tissue sarcoma | 0.95 | 0.91, 0.98 | * | 1.10 | 1.03, 1.16 | ** | 1.10 | 1.02, 1.17 | ** |
| Germ cell and gonadal neoplasms | 1.06 | 1.02, 1.10 | * | 1.11 | 1.05, 1.17 | * | 0.98 | 0.92, 1.05 | 0.63 |
| Carcinomas and epithelial neoplasms | 0.91 | 0.86, 0.96 | * | 1.12 | 1.05, 1.20 | * | 1.09 | 1.00, 1.19 | 0.04 |
| Other and unspecified neoplasms | 0.77 | 0.71, 0.83 | ** | 0.73 | 0.66, 0.80 | ** | 0.93 | 0.82, 1.04 | 0.19 |
| All cancers combined | 1.02 | 1.00, 1.04 | 0.07 | 1.07 | 1.04, 1.10 | ** | 1.05 | 1.02, 1.08 | * |
Unadjusted estimates.
Model 1+adjustment for GINI index quartile.
Model 2+adjustment for gross domestic product quartile.
For a 10° increase in absolute latitude.
**P<0.0001,
*P<0.01.
Estimated rate ratios for association between annual radiation and childhood cancer
|
|
|
| |||||||
|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
| 0.87 | 0.83, 0.91 | ** | 0.88 | 0.83, 0.92 | ** | 0.93 | 0.88, 0.98 | * |
| Lymphoid leukaemia | 0.82 | 0.78, 0.87 | ** | 0.84 | 0.79, 0.89 | ** | 0.94 | 0.88, 1.00 | 0.04 |
| Acute nonlymphocytic leukaemia | 0.90 | 0.85, 0.95 | * | 0.88 | 0.82, 0.93 | ** | 0.90 | 0.84, 0.96 | * |
|
| 1.24 | 1.16, 1.33 | ** | 1.09 | 1.02, 1.17 | 0.02 | 1.01 | 0.93, 1.09 | 0.86 |
| Hodgkins disease | 1.08 | 0.99, 1.17 | 0.10 | 1.10 | 1.00, 1.21 | 0.04 | 1.07 | 0.96, 1.19 | 0.20 |
| Non-Hodgkin lymphoma | 1.02 | 0.96, 1.09 | 0.51 | 1.03 | 0.97, 1.11 | 0.33 | 1.00 | 0.93, 1.08 | 0.98 |
| Brain and spinal neoplasms | 0.74 | 0.71, 0.79 | ** | 0.78 | 0.74, 0.82 | ** | 0.90 | 0.85, 0.94 | ** |
| Sympathetic nervous system tumours | 0.85 | 0.79, 0.92 | ** | 0.83 | 0.77, 0.90 | ** | 0.99 | 0.92, 1.06 | 0.80 |
| Retinoblastoma | 1.38 | 1.24, 1.54 | ** | 1.23 | 1.10, 1.38 | * | 1.02 | 0.91, 1.14 | 0.74 |
| Renal tumours | 0.92 | 0.87, 0.98 | 0.01 | 0.87 | 0.81, 0.93 | ** | 0.93 | 0.86, 0.99 | 0.04 |
| Hepatic tumours | 1.06 | 0.95, 1.18 | 0.34 | 0.94 | 0.84, 1.06 | 0.33 | 0.88 | 0.77, 1.00 | 0.05 |
| Malignant bone tumours | 0.95 | 0.91, 1.01 | 0.08 | 0.94 | 0.89, 0.99 | 0.02 | 0.99 | 0.93, 1.05 | 0.80 |
| Soft tissue sarcoma | 1.10 | 1.03, 1.19 | * | 0.97 | 0.90, 1.05 | 0.49 | 1.00 | 0.91, 1.09 | 0.95 |
| Germ cell and gonadal neoplasms | 0.82 | 0.77, 0.89 | ** | 0.78 | 0.73, 0.84 | ** | 0.86 | 0.79, 0.93 | * |
| Carcinomas and epithelial neoplasms | 0.93 | 0.84, 1.02 | 0.13 | 0.83 | 0.76, 0.91 | ** | 0.86 | 0.77, 0.96 | * |
| Other and unspecified neoplasms | 1.67 | 1.45, 1.93 | ** | 1.57 | 1.36, 1.83 | ** | 1.14 | 0.98, 1.34 | 0.09 |
| All cancers combined | 0.95 | 0.92, 0.99 | * | 0.92 | 0.88, 0.96 | ** | 0.94 | 0.90, 0.98 | * |
Unadjusted estimates.
Model 1+adjustment for GINI index quartile.
Model 2+adjustment for gross domestic product quartile.
For a categorical increase in radiation (category 1: 0–45; category 2: >45–60, category 3: >60 kWh m−2 per day).
**P<0.0001,
*P<0.01.